Lykos Therapeutics Announces FDA Advisory Committee Meeting to Review Investigational MDMA-Assisted Therapy for PTSD

Meeting to be held on June 4, 2024 First FDA Advisory Committee meeting for potential new PTSD treatment in 25 years SAN JOSE, Calif., May 6, 2024 /PRNewswire/ — Lykos Therapeutics (formerly MAPS Public Benefit Corporation) (“Lykos”), a company dedicated to transforming mental…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks